about
The global burden of trachoma: a reviewAntibiotics for trachomaAntibiotics for trachomaA randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the GambiaCurrent problems of perinatal Chlamydia trachomatis infectionsCan we eliminate trachoma?Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and controlTargeting antibiotics to households for trachoma controlCommunity risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trialField evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in TanzaniaMass drug administration for trachoma: how long is not long enough?Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma ProgramThe Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic TreatmentEliminating Trachoma in Areas with Limited DiseaseA rationale for continuing mass antibiotic distributions for trachomaIdentification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis.Reduction and return of infectious trachoma in severely affected communities in Ethiopia.TrachomaWhen can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countriesImportance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distributionActive trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?Progress and projections in the program to eliminate trachoma.Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communitiesTrachoma rapid assessments in Unity and Northern Bahr-el-Ghazal States, Southern Sudan.Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in TanzaniaBackground and current knowledge of Chlamydia pneumoniae and atherosclerosis.Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control.Importance of including borderline cases in trachoma grader certificationRifalazil pretreatment of mammalian cell cultures prevents subsequent Chlamydia infection.Active trachoma two years after three rounds of azithromycin mass treatment in Cheha District Gurage Zone, Southern EthiopiaSchool-Based Intervention: Evaluating the role of Water, Latrines and Hygiene Education on Trachoma and Intestinal Parasitic Infections in Ethiopia.Optimal seasonal timing of oral azithromycin for malaria.Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.Childhood mortality in a cohort treated with mass azithromycin for trachoma.Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.Pattern of antibiotic use in a trachoma-endemic region of Nepal: implications for mass azithromycin distribution.Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.Reliability of trachoma clinical grading--assessing grading of marginal cases.How reliable are tests for trachoma?--a latent class approach.
P2860
Q21562267-06FF5E70-96E0-4575-BE6C-684C47ADD98CQ24235833-EAC4B7B6-D447-42A6-A254-C4897E34219BQ24244258-A100A83C-6EFC-4A2F-BA0F-EFDE1595E829Q24670298-3CE43026-4771-4C23-AF96-ED176A64D692Q24801543-E7A341F1-ADB3-4E45-B42C-69279CBF7477Q28361082-698BAA40-3412-483D-8511-8ADA498FC8C8Q28471929-D5B46842-739C-4E35-A96C-02883D33F7D1Q28475981-11D014D8-AA74-4AC2-A8A9-3C4A1C8DA045Q28482497-2B4D21EF-951C-488F-A300-B1D5ECA5E3C3Q28534535-3B5D0F70-F28D-49A8-BC5D-5892CF95F494Q28544875-A5CD7256-4B30-4A23-93DD-3B07FD24AC02Q28550184-D1C4D44B-1702-48B8-86E8-C04E8531F509Q28552982-58C9687C-9577-4A71-85E7-44B480D27FE0Q29037878-B6FDAD92-1E85-4DD9-A939-738C0A2D2205Q33293477-E2F2B7D0-43FE-48BB-BF08-2E01E65B0BF4Q33381603-F66A8F48-9283-4392-B4DE-DD0C68CC7499Q33405255-4129029F-0886-4C75-AF5C-05F7C1273510Q33446794-78263EA5-6141-42F7-9E50-557B740DC228Q33468389-72A15CD7-4A7A-4CAA-BD2B-AE2DCA8707F4Q33496749-500A5A2E-307E-415C-8EF1-BE0ACFDA82E6Q33520204-726BD8DC-0A34-4E10-8FBA-167B8E717D29Q33584462-EBD27192-7B7D-4459-9D71-D40A8B2556B7Q33721962-EEB12CA3-07C9-40A8-8163-C9BD52A8F9D3Q33722125-4E696490-624C-4663-B73B-17B0FB0E7C0FQ33745187-152C5FE4-1537-433E-86B2-0EBFDF6093C4Q33851423-C1558EDF-44AD-49F9-8794-9E98B7ECA540Q33935003-01D41674-AA66-4B1C-892A-088BD738DB50Q34037913-398E95E0-8940-4A86-9F8D-C58A5A7D3050Q34138525-BC9A5AB8-01E4-47FC-A11D-975A25C0B78DQ34352208-EA98FB7B-92FC-4F95-90A2-A8D0044EDF65Q34449132-487CE1A0-B822-44B2-A42C-EB9623C6F13DQ34471042-98D43337-25A3-481C-B4E8-C5C5A90AF8CAQ34496220-90F4D5DC-C052-4712-8B3C-43AAA313BECBQ34855220-7B0923A2-6D92-46BD-8C04-079DBD84016BQ35019794-939A6058-42A0-46A8-8C9C-13FC0DDAE7AAQ35043690-2C35E1F4-DD5C-4A27-A405-4778BAAB8C1DQ35073785-7036AF3F-9D0A-484B-B589-0F1012516C42Q35116687-3C7E208A-A1C9-43B9-9A0A-91C3B666637EQ35160381-A67A9277-21FA-4546-938F-4D0DE02E8FEFQ35221151-C2F9A981-AEE5-4AF2-AE51-62A7A109283F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Azithromycin in control of trachoma.
@en
Azithromycin in control of trachoma.
@nl
type
label
Azithromycin in control of trachoma.
@en
Azithromycin in control of trachoma.
@nl
prefLabel
Azithromycin in control of trachoma.
@en
Azithromycin in control of trachoma.
@nl
P2093
P1433
P1476
Azithromycin in control of trachoma.
@en
P2093
C R Dawson
J Schachter
P304
P356
10.1016/S0140-6736(98)12387-5
P407
P577
1999-08-01T00:00:00Z